Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03117322Phase 4Completed
Phase 4, randomised, double-blind trial (4 arms). Primary endpoints: Change in the composition of the microbiota (firmicutes, bifidobacteria and lactobacilli) at 4 weeks, Change in consistency of feces at 4 weeks and 2 more. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03117322.